Claryle builds AI-driven analytics for pharmaceutical Medical Affairs and Brand teams — turning complex, scattered signals into clear guidance you can act on.
We help medical and commercial teams see what matters, understand why it matters, and know what to do next — designed from the ground up with medical affairs and compliance in mind.
We surface how your brand and its evidence show up across the channels that now shape clinical and access decisions.
Clear, comparable metrics over time — so progress is visible, contested ground is flagged, and gaps are easy to spot.
Every insight comes with specific, evidence-led actions — practical steps a team can take, framed for education not promotion.
We work business-to-business with the functions responsible for how a brand's science is understood in the market.
Teams are not short of data. They are short of time to turn it into a decision. Claryle exists to close that gap — quickly, defensibly, and with the rigour healthcare demands.
We are currently working with a small group of early partners as we grow.
If an insight can't be understood in a glance and acted on, it isn't finished. We design for the decision, not the dashboard.
Recommendations are grounded in what the evidence actually supports, framed for scientific education rather than promotion.
We build for the realities of medical affairs and regulated environments — considered, careful, and audit-friendly by default.
Whether you're exploring a pilot or just want to compare notes, we'd be glad to hear from you.
arunraju8222@gmail.com